53Biologics Digital Transformation

June 20, 2022 Patricia De La Madrid Comments: 0

53Biologics Digital Transformation

In a groundbreaking initiative, we’re embarking on the digitalization of our entire production process for biological products. By harnessing the power of data analytics and automation, we aim to enhance our decision-making capabilities, optimize manufacturing processes, and elevate the quality of our end products.

This project represents a significant step forward in our commitment to innovation and ensuring excellence in every aspect of our operations. Stay tuned for updates as we propel our company into a new era of efficiency and effectiveness.

DIGITALISATION OF THE PRODUCTION PLANT FOR THE MANUFACTURING OF BIOLOGICAL PRODUCTS

File no: FAR-010500-2022-2

Main objective of the project: digitalisation of BDI’s entire production process (Phase I and Phase II), in order to increase the company’s capacities for data exploitation and decision-making with regard to improving the quality of the end product and optimising the manufacturing process.

Deadline for completion: From 20/06/2022 to 22/11/2024

Project funded by the European Union – Next Generetion EU, the Ministry of Industry, Trade and Tourism and the Transformation and Resilience Recovery Plan.

Grant awarded: 216.217,00€.

DIGITALIZACION DE LA PLANTA DE PRODUCCION PARA LA FABRICACIÓN DE PRODUCTOS BIOLÓGICOS

Nº expediente: FAR-010500-2022-2

Objetivo principal del proyecto: digitalización del proceso de producción completo de BDI (Fase I y Fase II), para así incrementar las capacidades de la compañía encaminadas a la explotación del dato y la toma de decisiones en cuanto a la mejora de la calidad del producto final y la optimización del proceso de fabricación.

Plazo de realización: Desde el 20/06/2022 al 22/11/2024

Proyecto financiado por la Unión Europea – Next Generation EU, el Ministerio de Industria, Comercio y Turismo y el Plan de Recuperación Transformación y Resiliencia.

Subvención concedida: 216.217,00€

About 53Biologics:

53Biologics is a CDMO with specialized in biologics production, from pDNA to proteins. In order to serve as leaders in biologics development and manufacturing, our mission is to support you whenever you need us, starting in preclinical development up to commercialization.

For more information contact Patricia De La Madrid, Marketing & Business Development Manager at 53Biologics through this email: pdelamadrid@53biologics.com